德国社区药房流感疫苗接种三季调查:客户满意度、安全性与洞察
本研究通过匿名问卷评估2020至2023年德国多地药房流感疫苗接种试点中客户与药剂师的接受度、接种动机及不良事件率,共分析11571份回复。结果显示药房接种满意度高、重复接种意愿强,仅9例报告不良反应且无需紧急干预,药房主导接种安全且有助于提高接种可及性。
要点
- 44%参与者表示若不在药房则不会寻求接种,首次接种者中该比例为65%。
- 对信息供应和接种流程的满意度分别为88.5%和93.8%,重复接种意愿93.9%。
- 仅9例报告药房接种后不良反应,均无需紧急干预。
核心结论
- 药房主导的流感疫苗接种被认定为安全、受接种者欢迎,并能提高疫苗接种可接受性,有潜力提升德国不同人群的接种率。
研究设计与样本
- 研究通过匿名问卷收集2020年至2023年间德国多个地区流感疫苗接种试点项目的数据,问卷分为接种药剂师记录接种过程与受种者体验及观点两部分,共评估11571份回复。
主要发现
- 44%的参与者提到若不在药房则不会寻求接种,该比例在首次接种流感疫苗者中更高(65%)。
- 受种者对提供信息的满意度为88.5%,对接种流程的满意度为93.8%。
- 客户重复接种意愿为93.9%,在药房接受其他疫苗接种的可能性为79.7%。
- 所有调查者中仅9例报告药房接种后不良反应,均无需紧急干预。
关键数值与推荐
- 世界卫生组织建议重症高风险人群的流感疫苗接种率应超过75%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To address the challenges posed by influenza, its associated complications, and economic burden, the World Health Organization recommends a vaccination rate exceeding 75 % for populations at elevated risk of severe diseases. Presently, vaccination rates in Germany severely lag behind. To augment these rates, pilot projects have been initiated, allowing community pharmacists to administer vaccines. This study aimed to investigate the the acceptability of pharmacy-led influenza vaccinations among clients and pharmacists, clients' motivations to get vaccinated in community pharmacies, and the rate of adverse events during this process. Data were obtained through anonymous questionnaires from influenza vaccination pilot projects in various German regions between 2020 and 2023. The questionnaire consisted of two sections: one for the vaccinating pharmacist to record and document the vaccination process and one for the recipient, focusing on their experiences and views. In total 11,571 responses were evaluated. Notably, 44 % of participants mentioned they would not have sought vaccination outside a pharmacy setting. This percentage was higher (65 %) in those receiving their first influenza vaccination. Vaccinees reported high levels of satisfaction with the supplied information (88.5 %) and vaccination procedure (93.8 %). Furthermore, clients declared a high willingness to repeat the vaccination (93.9 %) and the possibility of receiving other vaccinations in pharmacies (79.7 %). Among all surveyees, only nine reported adverse reactions post pharmacy-administered vaccination, with none necessitating emergency intervention. Pharmacy-led influenza vaccinations were identified as safe, well-received by vaccinees and effective in increasing vaccination acceptability with the potential to enhance vaccination rates across diverse demographics in Germany.
引用
- Werthner Q, Faehrmann L, Och K, et al. Client satisfaction, safety, and insights from a three-season survey on influenza vaccinations delivered at community pharmacies in Germany. Vaccine. 2024. PMID: 39719772. doi:10.1016/j.vaccine.2024.126650
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。